Home > Journals > Minerva Endocrinology > Past Issues > Minerva Endocrinology 2021 September;46(3) > Minerva Endocrinology 2021 September;46(3):367-9

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Minerva Endocrinology 2021 September;46(3):367-9

DOI: 10.23736/S2724-6507.20.03163-6

Copyright © 2020 EDIZIONI MINERVA MEDICA

language: English

Assessment of RANKL/RANK/osteoprotegerin system expression in patients with hepatocellular carcinoma

Manuela CABIATI 1, Melania GAGGINI 1, Paolo DE SIMONE 2, Giuseppina BASTA 1, Amalia GASTALDELLI 1, Silvia DEL RY 1

1 Institute of Clinical Physiology, Italian Research Council (CNR), Pisa, Italy; 2 Department of Hepatobiliary Surgery and Liver Transplantation, University of Pisa Medical School Hospital, Pisa, Italy



top of page